Announced Tue, 14 Apr · 18:07 IST

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on March 31, 2026.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

—1-day move

₹22.00

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

—————+13.6+13.6+13.6+15.9+15.9—+20.5+17.5+10.2

Up moveDown movePending

AI summary

Hamps Bio Ltd has submitted a regulatory compliance certificate under SEBI (Depository Participants) Regulations, 2018 for Q4 FY2026. The filing appears to be a standard quarterly depository compliance certificate confirming proper maintenance of beneficial owner records or shareholding details as required under Regulation 74(5). The actual detailed content of the certificate was not accessible in the source document provided. This is a routine regulatory filing that depositories and listed companies must submit to SEBI on a quarterly basis.

Likely market impact

This is a routine compliance filing with no direct impact on the stock price or shareholder value. It simply confirms the company or its depository participant is maintaining required records as per SEBI regulations.